Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0RG8Z
|
|||
Former ID |
DIB011046
|
|||
Drug Name |
FPI-01
|
|||
Synonyms |
WT-1 therapeutic vaccine (cancer), Formula Pharmaceuticals
Click to Show/Hide
|
|||
Drug Type |
Vaccine
|
|||
Indication | Acute myeloid leukaemia [ICD-11: 2A60] | Phase 2 | [1] | |
Company |
Formula pharmaceuticals
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Wilms tumor protein (WT1) | Target Info | . | [2] |
KEGG Pathway | Transcriptional misregulation in cancer | |||
NetPath Pathway | FSH Signaling Pathway | |||
IL5 Signaling Pathway | ||||
Pathway Interaction Database | p73 transcription factor network | |||
Regulation of Telomerase | ||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | |||
Integrated Pancreatic Cancer Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040574) | |||
REF 2 | Clinical pipeline report, company report or official report of Formula Pharmaceuticals. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.